Browsing: Conditions

BioCryst Pharmaceuticals has appointed David W. Jenkins, Ph.D., as its first chief scientific officer, a newly created executive role designed to strengthen the company’s research strategy as it expands its rare disease pipeline through external innovation and partnerships. The appointment is effective immediately, with Jenkins reporting to Chief Research and Development Officer Dr. Sandeep Menon…

Doctors at Bai Jerbai Wadia Hospital for Children saved the life of a two-and-a-half-month-old baby girl after diagnosing and treating Familial Lipoprotein Lipase Deficiency (LPLD), an extremely rare inherited disorder that affects nearly 1 in 1 million people. Initially referred with suspected congenital heart disease, the infant was found to have dangerously high triglyceride levels…